Remove 2002 Remove Doctors Remove Governance
article thumbnail

Beneficiary inducements…don’t cross that line

YouCompli

The government contended the inducements were in the form of free blood glucose testing supplies and waiver of co-payments and deductibles for insulin. The whistleblower who brought this to the attention of the government worked in the business office and was privy to the waiving of copayments. million dollars.

article thumbnail

Black Health Should Matter More in America: The Undefeated Survey on Race and Health

Health Populi

Twice as many White people (15%) than Black people (7%) rated “government/politics/election-related” concerns as the third-ranking worry. In this essay, I re-visited the 2002 report from the Institutes of Medicine (IOM), Unequal Treatment , which laid out racial and ethnic disparities in health care.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmaceutical Manufacturers Ask EDVa to Allow Cost-Sharing Under the AKS

Healthcare Law Blog

Pharmaceutical manufacturers are challenging the breadth of the Federal Anti-Kickback Statute (“AKS”) in federal court, arguing that the government is harming the very vulnerable patients it aims to serve by prohibiting cost-sharing subsidies for life-saving oncology drugs. at 60203 (2002). 2, 2015). [10] 17, 2022). [11] 23, 2016). [13]

article thumbnail

Longevity Stalls Around the World And Wealth, More Concentrated

Health Populi

That core set of services covers consultations with doctors, tests and examinations, along with inpatient hospital care. Americans have relatively less access to a doctor when care is needed, the OECD report revealed. In addition to a relatively high level of avoidable mortality in America, the U.S. In the U.S.,

article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

435, 436 (2002). Even worse is standing based on the “considerable mental and emotional stress on emergency-room doctors,” purported injury from “divert[ing] time and resources away from their ordinary practice to treat [adverse reaction] patients, and even the possibility of increased malpractice insurance costs. Gore ,” 35 Ind.

FDA 52
article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

435, 436 (2002). Even worse is standing based on the “considerable mental and emotional stress on emergency-room doctors,” purported injury from “divert[ing] time and resources away from their ordinary practice to treat [adverse reaction] patients, and even the possibility of increased malpractice insurance costs. Gore ,” 35 Ind.

FDA 59
article thumbnail

California Appellate Court Reaffirms Federal Preemption, Learned Intermediary Doctrine in Amiodarone Cases

Drug & Device Law

3, 2002) (to be published), the California Court of Appeal held that federal law preempts state law failure-to-warn claims alleging that branded and generic drug manufacturers did not ensure that patients received FDA-approved Medication Guides for amiodarone, a heart medicine. In Amiodarone Cases , No. A161023, 2022 WL 16646728 (Cal.

FDA 52